These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 37215925

  • 1. A potential biological signature of 7-methylguanosine-related lncRNA to predict the immunotherapy effects in bladder cancer.
    Xie S, He J, Feng B, Rao D, Wang S, He Y.
    Heliyon; 2023 May; 9(5):e15897. PubMed ID: 37215925
    [Abstract] [Full Text] [Related]

  • 2. Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response.
    Cao J, Liang Y, Gu JJ, Huang Y, Wang B.
    Front Genet; 2022 May; 13():991162. PubMed ID: 36353118
    [Abstract] [Full Text] [Related]

  • 3. Construction and validation of a prognostic signature for mucinous colonic adenocarcinoma based on N7-methylguanosine-related long non-coding RNAs.
    Gao Y, Ren J, Chen K, Guan G.
    J Gastrointest Oncol; 2024 Feb 29; 15(1):203-219. PubMed ID: 38482248
    [Abstract] [Full Text] [Related]

  • 4. Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer.
    Xiong X, Chen C, Li X, Yang J, Zhang W, Wang X, Zhang H, Peng M, Li L, Luo P.
    Front Oncol; 2023 Feb 29; 13():972558. PubMed ID: 37064115
    [Abstract] [Full Text] [Related]

  • 5. Predicting prognosis and immune responses in hepatocellular carcinoma based on N7-methylguanosine-related long noncoding RNAs.
    Dai YY, Gao YP, Chen LX, Liu JS, Zeng C, Zhou JD, Wu HL.
    Front Genet; 2022 Feb 29; 13():930446. PubMed ID: 36110218
    [Abstract] [Full Text] [Related]

  • 6. An innovative model based on N7-methylguanosine-related lncRNAs for forecasting prognosis and tumor immune landscape in bladder cancer.
    Ren L, Yang X, Liu J, Wang W, Liu Z, Lin Q, Huang B, Pan J, Mao X.
    Cancer Cell Int; 2023 May 08; 23(1):85. PubMed ID: 37158958
    [Abstract] [Full Text] [Related]

  • 7. Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs.
    Liu D, Xu S, Chang T, Ma S, Wang K, Sun G, Chen S, Xu Y, Zhang H.
    Front Immunol; 2022 May 08; 13():916800. PubMed ID: 35860239
    [Abstract] [Full Text] [Related]

  • 8. Novel m7G-related lncRNA signature for predicting overall survival in patients with gastric cancer.
    Zhao B, Fang F, Liao Y, Chen Y, Wang F, Ma Y, Wei C, Zhao J, Ji H, Wang D, Tang D.
    BMC Bioinformatics; 2023 Mar 19; 24(1):100. PubMed ID: 36935487
    [Abstract] [Full Text] [Related]

  • 9. M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma.
    Pan J, Huang Z, Lin H, Cheng W, Lai J, Li J.
    BMC Cancer; 2022 Nov 04; 22(1):1132. PubMed ID: 36333719
    [Abstract] [Full Text] [Related]

  • 10. Comprehensive analysis of nine m7G-related lncRNAs as prognosis factors in tumor immune microenvironment of hepatocellular carcinoma and experimental validation.
    Wang T, Zhou Z, Wang X, You L, Li W, Zheng C, Zhang J, Wang L, Kong X, Gao Y, Sun X.
    Front Genet; 2022 Nov 04; 13():929035. PubMed ID: 36081998
    [Abstract] [Full Text] [Related]

  • 11. Development and validation of a model based on immunogenic cell death related genes to predict the prognosis and immune response to bladder urothelial carcinoma.
    Chen L, Lin J, Wen Y, Chen Y, Chen CB.
    Front Oncol; 2023 Nov 04; 13():1291720. PubMed ID: 38023241
    [Abstract] [Full Text] [Related]

  • 12. N7-Methylguanosine-Related lncRNAs: Integrated Analysis Associated With Prognosis and Progression in Clear Cell Renal Cell Carcinoma.
    Ming J, Wang C.
    Front Genet; 2022 Nov 04; 13():871899. PubMed ID: 35495133
    [Abstract] [Full Text] [Related]

  • 13. N7-methylguanosine-related lncRNAs: Predicting the prognosis and diagnosis of colorectal cancer in the cold and hot tumors.
    Wu JY, Song QY, Huang CZ, Shao Y, Wang ZL, Zhang HQ, Fu Z.
    Front Genet; 2022 Nov 04; 13():952836. PubMed ID: 35937987
    [Abstract] [Full Text] [Related]

  • 14. Identification of a Novel N7-Methylguanosine-Related LncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma and Experiment Verification.
    Yang C, Zhang L, Hao X, Tang M, Zhou B, Hou J.
    Curr Oncol; 2022 Dec 28; 30(1):430-448. PubMed ID: 36661684
    [Abstract] [Full Text] [Related]

  • 15. Prognostic Signature and Tumor Immune Landscape of N7-Methylguanosine-Related lncRNAs in Hepatocellular Carcinoma.
    Wei W, Liu C, Wang M, Jiang W, Wang C, Zhang S.
    Front Genet; 2022 Dec 28; 13():906496. PubMed ID: 35938009
    [Abstract] [Full Text] [Related]

  • 16. Risk Model and Immune Signature of m7G-Related lncRNA Based on Lung Adenocarcinoma.
    Zhang C, Zhou D, Wang Z, Ju Z, He J, Zhao G, Wang R.
    Front Genet; 2022 Dec 28; 13():907754. PubMed ID: 35754819
    [Abstract] [Full Text] [Related]

  • 17. An m7G-related lncRNA signature predicts prognosis and reveals the immune microenvironment in bladder cancer.
    Li Z, Zhao J, Huang X, Wang J.
    Sci Rep; 2023 Mar 15; 13(1):4302. PubMed ID: 36922569
    [Abstract] [Full Text] [Related]

  • 18. N7-methylguanosine-related lncRNAs: Distinction between hot and cold tumors and construction of predictive models in colon adenocarcinoma.
    Cheng Z, Wang J, Xu Y, Jiang T, Xue Z, Li S, Zhao Y, Song H, Song J.
    Front Oncol; 2022 Mar 15; 12():951452. PubMed ID: 36185235
    [Abstract] [Full Text] [Related]

  • 19. Identification of N7-methylguanosine-related lncRNAs for the risk stratification of hepatocellular carcinoma.
    Li Y, Zhao K, Wu R, Wang J, Wang Q, Xiong Q, Xie F, Lei H, Feng P.
    J Gastrointest Oncol; 2023 Jun 30; 14(3):1392-1411. PubMed ID: 37435203
    [Abstract] [Full Text] [Related]

  • 20. A novel m7G-related lncRNA risk model for predicting prognosis and evaluating the tumor immune microenvironment in colon carcinoma.
    Yang S, Zhou J, Chen Z, Sun Q, Zhang D, Feng Y, Wang X, Sun Y.
    Front Oncol; 2022 Jun 30; 12():934928. PubMed ID: 35992788
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.